May 11, 2026
12:00 PM – 1:30 PM PT
The BC Centre on Substance Use is pleased to offer this upcoming webinar on the Clinical Management of Medetomidine-Related Presentations. This webinar is intended for clinicians managing medetomidine-related care in acute settings, with a focus on identifying key clinical features and offering practical insights into clinical decision-making around management approaches. We are pleased to feature guest clinicians from Philadelphia, PA, who bring extensive experience to this dialogue-oriented session.
Philadelphia is widely viewed as the epicentre of medetomidine-adulterated unregulated drugs, where clinicians have been managing an increasing volume of complex medetomidine-related cases since 2024. Real-world case studies will be discussed, and time for Q&A will be provided: we encourage attending clinicians to come with practice-based questions.
Hosts
Dr. Paxton Bach, MSc – Co-Medical Director BC Centre on Substance Use; Clinical Assistant Professor, Department of Medicine, UBC; General Internist and Addiction Medicine Physician, St. Paul’s Hospital
Dr. Alexis Crabtree, MPH PhD – Public Health Physician, Harm Reduction and Substance Use Services, BC Centre for Disease Control Clinical
Guests
Dr. Bridget R. Durkin, MBE – Assistant Professor of Clinical Medicine, Medical Director of Addiction Medicine Consult Team at the Hospital of the University of Pennsylvania; Co-Chair of the Opioid Task Force for University of Pennsylvania Health System
Emily Casey, Pharm.D., BCPMP – Clinical Pharmacy Specialist, Pain Management and Substance Use, Hospital of the University of Pennsylvania
Dr. Ashish Thakrar, MS – Assistant Professor of Medicine, Division of General Internal Medicine, University of Pennsylvania School of Medicine
Dr. Wei-Teng Yang, MPH – Assistant Professor of Clinical Medicine, Director of Infectious Diseases Addiction Medicine Integration, University of Pennsylvania Health System, Penn Center for Addiction Medicine and Policy